Evidence map›Paper›PMID 40062018›Full record

ArticleCureus2025

Anti-nuclear Matrix Protein 2 Antibody-Positive Dermatomyositis Relapse With Preceding Panniculitis.

Hirokazu Taguchi, Yoshitaka Ueda, Yohya Shigehara, Naoto Yokogawa

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hirokazu TaguchiDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, JPN.
Yoshitaka UedaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, JPN.
Yohya ShigeharaDepartment of Dermatology, Tokyo Metropolitan Tama Medical Center, Fuchu, JPN.
Naoto YokogawaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by cutaneous lesions such as heliotrope rash, Gottron's papules, and Gottron's sign. Panniculitis is rarely reported as a skin manifestation of DM. Herein, we present a case of anti-nuclear matrix protein 2 antibody (NXP-2)-positive DM relapse with panniculitis in the absence of muscle symptoms. A 32-year-old female patient was referred to our department. Nine years ago, she was diagnosed with DM and had received prednisolone (PSL) and tacrolimus therapy. However, she discontinued her visits four years ago. She most recently presented with erythematous lesions on the right thigh and buttocks without any muscle symptoms. Thirteen days later, she experienced upper limb weakness. Laboratory findings at her current presentation demonstrated elevated serum creatine kinase levels and positivity for anti-NXP-2 antibody. A skin biopsy of the erythema on her left thigh demonstrated findings consistent with healed panniculitis. Based on these findings, an anti-NXP-2 antibody-positive DM relapse was diagnosed. Her symptoms resolved with PSL and tacrolimus therapy. It is important to recognize that panniculitis is a significant, cutaneous manifestation of DM and can present as the initial manifestation of a DM relapse even in the absence of muscle symptoms.

Indexed as

anti-nuclear matrix protein 2 antibodydermatomyositislipoatrophymyositis-specific antibodypanniculitisskin biopsy

Identifiers

PMID40062018
PMCPMC11890021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.